Sangamo Therapeutics, Inc. (SGMO) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Sangamo Therapeutics, Inc. (SGMO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $30.7M, listed on PNK, employing roughly 127 people, carrying a beta of 1.29 to the broader market. Sangamo Therapeutics, Inc. Led by Alexander D. Macrae Ch.B, public since 2000-04-06.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for SGMO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →